Beigene Ltd
HKEX:6160
Beigene Ltd
Gross Profit
Beigene Ltd
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Beigene Ltd
HKEX:6160
|
Gross Profit
¥14.7B
|
CAGR 3-Years
108%
|
CAGR 5-Years
67%
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Gross Profit
¥5.1B
|
CAGR 3-Years
14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Gross Profit
¥4.5B
|
CAGR 3-Years
34%
|
CAGR 5-Years
45%
|
CAGR 10-Years
N/A
|
|
B
|
Beijing Tiantan Biological Products Corp Ltd
SSE:600161
|
Gross Profit
¥2.7B
|
CAGR 3-Years
16%
|
CAGR 5-Years
13%
|
CAGR 10-Years
10%
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Gross Profit
¥13.6B
|
CAGR 3-Years
28%
|
CAGR 5-Years
33%
|
CAGR 10-Years
40%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Gross Profit
¥1.8B
|
CAGR 3-Years
53%
|
CAGR 5-Years
57%
|
CAGR 10-Years
N/A
|
See Also
What is Beigene Ltd's Gross Profit?
Gross Profit
14.7B
CNY
Based on the financial report for Dec 31, 2023, Beigene Ltd's Gross Profit amounts to 14.7B CNY.
What is Beigene Ltd's Gross Profit growth rate?
Gross Profit CAGR 5Y
67%
Over the last year, the Gross Profit growth was 92%. The average annual Gross Profit growth rates for Beigene Ltd have been 108% over the past three years , 67% over the past five years .